6 Jul 2021 11:55
6 July 2021
Â
Microsaic Systems plc
Â
("Microsaic" or "Company")
Â
Investor Presentation
Â
Microsaic (AIM: MSYS), the developer of point of need mass spectrometry ("MS") systems and solutions, is pleased to announce that Glenn Tracey, CEO, and Bevan Metcalf, FD, will provide a live presentation relating to the trading update for H1 2021 (announced on 6 July 2021) via the Investor Meet Company platform on 8 July 2021 at 1:00 pm BST.
Â
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9.00 am BST the day before the meeting or at any time during the live presentation.
Â
Investors can sign up to Investor Meet Company for free and add to meet Microsaic Systems plc via:
https://www.investormeetcompany.com/microsaic-systems-plc/register-investor
Â
Investors who already follow Microsaic Systems plc on the Investor Meet Company platform will automatically be invited.
Â
Â
Enquiries: | |
Microsaic Systems plc Glenn Tracey, CEO Bevan Metcalf, FD | +44 (0)1483 751 577 |
N+1 Singer (Nominated Adviser & Joint Broker) | +44 (0)20 7496 3000 |
Aubrey Powell / George Tzimas (Investment Banking)  | |
Turner Pope Investments (TPI) Limited (Joint Broker) Andy Thacker / James Pope | +44 (0)Â 20 3657 0050 |
Â
About Microsaic (www.microsaic.com)
Â
Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested ÂŁ30m over the last 20 years before and after the IPO, Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.
Â
Microsaic's products and systems are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing, and point-of-need applications.Â
Â
Follow the stocks